SkyQuest Technology Group recently introduced Genomics Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Genomics Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Genomics Market size was valued at USD 37.1 billion in 2023 and is poised to grow from USD 41.66 billion in 2024 to USD 105.39 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).
Genomics is the study of genomes, which is the structure, function, evolution and mapping of an organism’s DNA. Overall, the market has influenced this area of human life in a great way over the years. Hence, medicine and biomedical sciences are in the process of a rapid transformation due to the genomics revolution. The increasing global cancer incidence has led to higher levels of government support in the form of grants for genomics projects. The idea of personalized medicine has been made possible by studying the Human Genome and has revolutionized the way clinical oncology and rare genetic disorders are managed/ treated.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/genomics-market
The 2025 global Genomics Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Genomics Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Genomics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Offering
Products, Services
Product Type
Reagents, Kits, And Consumables, Instruments, Bioinformatics Tools
Technology
Sequencing, PCR, Gene Editing, Flow Cytometry, Microarrays, In Situ Hybridization, Other Technologies
Service Type
Genomic Profiling and Sequencing Services, Sample Preparation and Library Preparation Services, Bioinformatics Services
Application
Drug Discovery and Development, Diagnostics (Infectious Diseases, Reproductive Health, Other Diagnostic Applications, Agriculture And Animal Research), Other Applications
Study Type
Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, Other Study Types
End User
Hospitals, Diagnostic Laboratories, Clinics, Academic and Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Genomics Market – Regional Analysis:
– Genomics North America Market includes (Canada, Mexico, USA)
– Genomics Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Genomics Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Genomics South America Market includes (Brazil, Argentina)
– Genomics Oceania Market (Australia & New Zealand)
Top Market Players in Genomics Market are:
Illumina, Inc. (US)
Thermo Fisher Scientific (US)
Qiagen N.V. (Netherlands)
BGI Group (China)
F. Hoffmann-La Roche AG (Switzerland)
Danaher Corporation (US)
Pacific Biosciences of California, Inc. (US)
Oxford Nanopore Technologies, Ltd. (United Kingdom)
Eurofins Scientific SE (Luxembourg)
Bio-Rad Laboratories, Inc. (US)
Myriad Genetics, Inc. (US)
Fluidigm Corporation (US)
PerkinElmer, Inc. (US)
Twist Bioscience Corporation (US)
Natera, Inc. (US)
Veracyte, Inc. (US)
Personalis, Inc. (US)
10x Genomics, Inc. (US)
Quest Diagnostics (US)
Genomics Key Market Trends:
Switch to a customised Illumina global screening array (GSA) microarray instead of the Illumina OmniExpress chip. The OmniExpress chip from Illumina will be phased out in favour of the GSA chip. As a result, organisations like Ancestry.com will be obliged to convert to the GSA, acquire Thermo Fisher Scientific goods, or implement next-generation sequencing technology if they continue to utilize this equipment.
Third-Generation Sequencing (TGS) marks the third revolution in sequencing technology. To stay up with the shifting trends, several firms began developing TGS technology. These new tools allow us to examine genomes in higher detail than ever before. Next-generation sequencing (NGS) has raised the bar in genomic research by allowing for high-throughput sequencing that is quicker, more efficient, and less expensive than Sanger sequencing.
Also Read –
https://en.everybodywiki.com/Cold_Plasma
https://www.xing.com/discover/detail-activities/6743198502.f56448?trackingTokens=disco.module.me-feed%3A2491b9d30bc811f088d286b0ee840ce2%3A0.6743198502.activities_activity&sc_o=discover_stream_object_content_click&sc_o_PropActionOrigin=discover_mefeed_DiscoMeFeedModule
Forward-Looking Insights
The Genomics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
